Reduction in the population prevalence of hepatitis C virus viraemia among people who inject drugs associated with scale‐up of direct‐acting anti‐viral therapy in community drug services: real‐world data-Reference-Cited by-同舟云学术

Reduction in the population prevalence of hepatitis C virus viraemia among people who inject drugs associated with scale‐up of direct‐acting anti‐viral therapy in community drug services: real‐world data

Published:2021-05-05 Issue:10 Volume:116 Page:2893-2907
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Palmateer Norah E.¹²^ORCID,McAuley Andrew¹²,Dillon John F.³,McDonald Scott¹,Yeung Alan¹²^ORCID,Smith Shanley¹²,Barclay Stephen¹⁴,Hayes Peter⁵,Shepherd Samantha J.⁶,Gunson Rory N.⁶,Goldberg David J.¹²,Hickman Matthew⁷^ORCID,Hutchinson Sharon J.¹²

Affiliation:

1. Glasgow Caledonian University Cowcaddens Road Glasgow G4 0BA UK

2. Public Health Scotland Glasgow UK

3. University of Dundee Dundee UK

4. Glasgow Royal Infirmary Glasgow UK

5. Royal Infirmary of Edinburgh Edinburgh UK

6. West of Scotland Specialist Virology Centre Glasgow UK

7. University of Bristol Bristol UK

Funder

National Institute for Social Care and Health Research

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/add.15459

Reference38 articles.

1. Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs

2. World Health Organization (WHO).Global Health Sector Strategy on Viral Hepatitis 2016–2021: towards ending viral hepatitis. Geneva: World Health Organization;2016. Available at:https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/(accessed 7 October 2020).

3. Strategies for the treatment of Hepatitis C in an era of interferon-free therapies: what public health outcomes do we value most?

4. Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy

5. Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards eliminating hepatitis C as a public health threat: different speeds, different needs;Eurosurveillance;2024-07-25

2. Decrease in active hepatitis C infection among people who use drugs in Madrid, Spain, 2017 to 2023: a retrospective study;Eurosurveillance;2024-07-18

3. Changes in hepatitis C virus prevalence and incidence among people who inject drugs in the direct acting antiviral era;International Journal of Drug Policy;2024-06

4. Evaluating the effect of direct-acting antiviral agent treatment scale-up on Hepatitis C virus prevalence among people who inject drugs in UK;International Journal of Drug Policy;2024-06

5. Towards elimination of hepatitis C in Oslo: Cross-sectional prevalence studies among people who inject drugs;International Journal of Drug Policy;2024-01